Table 2.
Patient | Brain-MD |
CSF-MD |
||||||||
---|---|---|---|---|---|---|---|---|---|---|
Glucose (mmol/L) | Lactate (mmol/L) | Pyruvate (μmol/L) | LPR | Glycerol (μmol/L) | Glucose (mmol/L) | Lactate (mmol/L) | Pyruvate (μmol/L) | LPR | Glycerol (μmol/L) | |
1 | 1.9 (0.9–3.2) n = 45 | 5.9 (3.1–8.5) n = 45 | 141 (93–224) n = 44 | 49 (34–54) n = 45 | 106 (89–125) n = 45 | 4.7 (2.4–5.0) n = 31 | 2.0 (1.9–2.2) n = 32 | 73 (62–83) n = 30 | 27 (24–33) n = 31 | 57 (27–62) n = 31 |
2 | 1.4 (0.6–1.8) n = 157 | 4.9 (4.1–6.2) n = 154 | 148 (135–168) n = 156 | 33 (30–35) n = 154 | 181 (143–310) n = 157 | 5.0 (4.8–5.4) n = 113 | 2.9 (2.5–3.4) n = 112 | 85 (75–100) n = 105 | 34 (28–42) n = 105 | 73 (44–103) n = 114 |
3 | 0.6 (0.5–0.8) n = 163 | 3.5 (2.8–4.2) n = 160 | 100 (72–144) n = 149 | 35 (29–43) n = 148 | 361 (242–874) n = 158 | 4.9 (4.3–5.5) n = 110 | 2.4 (2.2–2.7) n = 108 | 113 (105–123) n = 94 | 22 (19–25) n = 93 | 32 (22–40) n = 111 |
4 | 1.6 (1.1–2.1) n = 241 | 2.6 (2.3–3.1) n = 263 | 112 (88–126) n = 265 | 24 (22–29) n = 262 | 987 (706–1420) n = 259 | 5.5 (4.4–6.9) n = 125 | 1.8 (1.6–2.1) n = 124 | 82 (67–99) n = 124 | 22 (20–25) n = 124 | 38 (32–51) n = 125 |
5 | 4.0 (3.2–4.5) n = 129 | 2.5 (2.0–3.2) n = 124 | 130 (112–147) n = 122 | 19 (16–25) n = 118 | 483 (243–877) n = 127 | 4.8 (4.5–5.1) n = 125 | 2.3 (1.9–2.5) n = 123 | 94 (80–111) n = 122 | 23 (18–29) n = 116 | 99 (86–112) n = 125 |
6 | 5.9 (5.5–6.3) n = 55 | 2.1 (1.9–2.4) n = 58 | 130 (122–149) n = 50 | 15 (15–18) n = 46 | 87 (77–107) n = 58 | 4.8 (4.6–5.1) n = 97 | 1.7 (1.6–1.9) n = 96 | 63 (60–69) n = 96 | 27 (24–29) n = 92 | 29 (25–34) n = 96 |
7 | 1.6 (1.1–2.2) n = 112 | 7.4 (6.2–8.6) n = 119 | 269 (255–284) n = 118 | 27 (23–32) n = 125 | 120 (66–238) n = 118 | 5.1 (4.6–5.5) n = 110 | 3.2 (2.9–3.4) n = 116 | 124 (108–158) n = 114 | 25 (20–31) n = 119 | 44 (39–57) n = 115 |
8 | 0.5 (0.3–1.1) n = 75 | 7.2 (4.9–7.8) n = 67 | 157 (128–185) n = 68 | 45 (40–49) n = 64 | 184 (91–359) n = 70 | 4.3 (3.9–4.8) n = 147 | 2.7 (2.5–2.9) n = 149 | 112 (101–124) n = 146 | 24 (23–27) n = 146 | 64 (55–76) n = 148 |
9 | 1.2 (0.8–1.5) n = 213 | 5.0 (3.6–6.3) n = 230 | 137 (92–173) n = 216 | 35 (31–40) n = 215 | 87 (58–115) n = 215 | 5.2 (4.6–6.0) n = 150 | 3.6 (3.2–4.1) n = 151 | 151 (138–172) n = 148 | 24 (22–26) n = 145 | 58 (38–72) n = 149 |
10 | 1.0 (0.8–1.3) n = 89 | 2.6 (2.2–3.0) n = 93 | 102 (94–117) n = 89 | 24 (22–26) n = 89 | 2273 (1817–2529) n = 94 | 5.6 (4.7–7.0) n = 123 | 4.7 (4.1–5.1) n = 128 | 199 (179–228) n = 125 | 23 (20–26) n = 125 | 82 (66–113) n = 127 |
11 | 0.9 (0.8–1.2) n = 151 | 3.4 (2.9–3.9) n = 152 | 112 (92–125) n = 148 | 32 (29–34) n = 145 | 451 (269–1133) n = 153 | 5.4 (4.9–5.9) n = 150 | 2.8 (2.6–3.1) n = 145 | 100 (94–114) n = 142 | 28 (25–30) n = 139 | 66 (58–75) n = 147 |
12 | 1.0 (0.7–1.2) n = 100 | 5.2 (4.5–5.8) n = 99 | 166 (154–183) n = 99 | 31 (28–34) n = 99 | 114 (71–149) n = 102 | 4.7 (4.2–5.1) n = 106 | 2.3 (2.0–2.7) n = 106 | 77 (72–89) n = 104 | 29 (26–34) n = 104 | 40 (37–46) n = 107 |
13 | 0.2 (0.1–1.1) n = 42 | 17.1 (15.3–18.8) n = 62 | 133 (114–270) n = 58 | 129 (49–143) n = 62 | 133 (118–153) n = 55 | 5.6 (5.3–5.8 n = 50 | 2.4 (2.2–2.6) n = 50 | 126 (99–149) n = 50 | 20 (17–23) n = 50 | 53 (46–62) n = 49 |
14 | 1.8 (1.5–2.4) n = 54 | 14.9 (13.8–16.2) n = 54 | 447 (365–528) n = 54 | 33 (31–37) n = 58 | 605 (495–892) n = 54 | 4.3 (3.3–5.2) n = 51 | 4.8 (3.3–5.8) n = 51 | 239 (194–267) n = 49 | 19 (18–23) n = 53 | 49 (38–71) n = 50 |
Brain-MD and CSF-MD parameters in median values, with 1st–3rd quartile in parenthesis. Sample size is the amount of MD samples acquired of the specific metabolite for each patient. The patients with pericontusional microdialysis catheters are in white rows, while the rows of patients with ipsilateral microdialysis catheters are gray. The amount of samples represents total monitored time (h).